BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33770352)

  • 1. Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis.
    Karaca Z; Grossman A; Kelestimur F
    Rev Endocr Metab Disord; 2021 Jun; 22(2):179-204. PubMed ID: 33770352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome.
    Calis M; Gökçe C; Ates F; Ulker S; Izgi HB; Demir H; Kirnap M; Sofuoglu S; Durak AC; Tutus A; Kelestimur F
    J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
    Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis.
    Ach T; Yosra H; Jihen M; Abdelkarim Asma B; Maha K; Molka C; Rouatbi S; Monia Z; Ach K
    Endocr J; 2018 Sep; 65(9):935-942. PubMed ID: 29952338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges.
    Martin-Grace J; Dineen R; Sherlock M; Thompson CJ
    Clin Chim Acta; 2020 Jun; 505():78-91. PubMed ID: 32035851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Short Synacthen (Corticotropin) Test Can Be Used to Predict Recovery of Hypothalamo-Pituitary-Adrenal Axis Function.
    Pofi R; Feliciano C; Sbardella E; Argese N; Woods CP; Grossman AB; Jafar-Mohammadi B; Gleeson H; Lenzi A; Isidori AM; Tomlinson JW
    J Clin Endocrinol Metab; 2018 Aug; 103(8):3050-3059. PubMed ID: 29846658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study.
    Miyauchi T; Tsuruta R; Fujita M; Kaneko T; Kasaoka S; Maekawa T
    BMC Infect Dis; 2009 Dec; 9():209. PubMed ID: 20021698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test.
    Tordjman K; Jaffe A; Trostanetsky Y; Greenman Y; Limor R; Stern N
    Clin Endocrinol (Oxf); 2000 May; 52(5):633-40. PubMed ID: 10792344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of morning basal serum cortisol in assessment of hypothalamic pituitary-adrenal axis.
    Yip CE; Stewart SA; Imran F; Clarke DB; Mokashi A; Kaiser SM; Imran SA
    Clin Invest Med; 2013 Aug; 36(4):E216-22. PubMed ID: 23906493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.
    Hamrahian AH; Yuen KC; Gordon MB; Pulaski-Liebert KJ; Bena J; Biller BM
    Pituitary; 2016 Jun; 19(3):332-41. PubMed ID: 26897383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-Pituitary Axis Function and Adrenal Insufficiency in COVID-19 Patients.
    Durcan E; Hacioglu A; Karaca Z; Unluhizarci K; Gonen MS; Kelestimur F
    Neuroimmunomodulation; 2023; 30(1):215-225. PubMed ID: 37703857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.
    Balasko A; Zibar Tomsic K; Kastelan D; Dusek T
    J Neuroendocrinol; 2022 Aug; 34(8):e13172. PubMed ID: 35726348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery.
    English K; Inder WJ; Weedon Z; Dimeski G; Sorbello J; Russell AW; Duncan EL; Cuneo R
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):35-43. PubMed ID: 28329436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.